Resources from the same session
The clinical/academia perspective
Presenter: Stefan Michiels
Session: Fast tracking drug development by early screening for tumour-agnostic potential: Trialist, sponsor and regulator views
Resources:
Slides
Webcast
The regulator perspective
Presenter: Harpreet Singh
Session: Fast tracking drug development by early screening for tumour-agnostic potential: Trialist, sponsor and regulator views
Resources:
Slides
Webcast
The biotech perspective
Presenter: Robert Doebele
Session: Fast tracking drug development by early screening for tumour-agnostic potential: Trialist, sponsor and regulator views
Resources:
Slides
Webcast
Panel discussion
Session: Fast tracking drug development by early screening for tumour-agnostic potential: Trialist, sponsor and regulator views
Resources:
Webcast